JPRN-UMIN000021968Not yet recruiting未知
A randomized crossover study between insulin glulisine and insulin aspart in patients with type 1 diabetes - A randomized crossover study between insulin glulisine and insulin aspart in patients with type 1 diabetes
Osaka City University Pediatrics0 sites25 target enrollmentStarted: April 18, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3years-old to 50years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •# pregnant # oral steroid therapy # significant obesity # advanced diabetes coomplication
Investigators
Similar Trials
Recruiting
Not Applicable
Blood sugar control after bypass operation - insulin vs oral medicatioheart disease, diabetesSLCTR/2014/024ational Hospital of Sri Lanka330
Completed
Not Applicable
Two-way crossover comparison of insulin glargine and insulin degludec in basal-bolus therapy using continuous glucose monitoring.type 1 diabetes or type 2 diabetesJPRN-UMIN000013285Kitasato University Kitasato Institute Hospital50
Not yet recruiting
Not Applicable
A pilot study of association between insulin resistance markers in T2DM patients with or without coronary artery diseaseCoronary Artery DiseaseT2DM patients with Coronary Artery DiseaseType 2 Diabetes MellitusTriglyceride Glucose index (TyG)Homeostatic Model Assessment Insulin Resistance (HOMA-IR)Insulin ResistanceTCTR20220804006Theptarin Hospital50
Completed
Not Applicable
Evaluating the effect of a new supplement on recovery after open heart surgeryIRCT201312102480N3Shiraz University of Medical Sciences92
Active, not recruiting
Not Applicable
A Randomized Trial Comparing either Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects with Type 2 Diabetes who were previously treated by basal insulin Glargine with either metformin or metformin and sulfonylurea - NDMedDRA version: 9.1Level: LLTClassification code 10012594Type 2 DiabetesEUCTR2009-009500-39-ITELI LILLY760